inPractice® - ARTEMIS

Special Considerations in the Management of HIV-Infected Patients From Minority Communities

Authors: Bisola Ojikutu, MD, MPH; Valerie E. Stone, MD, MPH (More Info)
Section Editor: Judith S. Currier, MD, MSc
Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
Last Reviewed: 7/9/18 (What's New)

Summary

ARTEMIS study compared darunavir/ritonavir with lopinavir/ritonavir in treatment-naive patients also receiving emtricitabine/tenofovir DF^{[Andrade-Villanueva 2008]}
Efficacy did not differ by race
Differences in the incidence of adverse events were not considered clinically relevant

Action required

Login now to access all of your entitled content
or
View additional options to gain access to this content

Keywords: Initial Antiretroviral Therapy, Minority-Ethnic Communities, Pharmacokinetics, Special Populations